Nath Biogene India Ltd.

Nath Biogene India Ltd. (NSE/BSE: NATHBIOGEN) is an Indian publicly listed company quoted on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The company operates a diversified business across multiple verticals of the Indian economy. Its securities trade under ISIN INE448G01010. It is listed under the EQ series. As of the most recent update, Nath Biogene India Ltd. carries an equity market capitalisation of approximately ₹327 Cr, which places it among the tracked constituents of the Diversified sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by Nath Biogene India Ltd. via stock-exchange filings. For investors and researchers tracking diversified listings, NATHBIOGEN provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates Nath Biogene India Ltd.'s core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.